KT5-12

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameKT5-12
Drug Alias NameKT5-915KT5-12
ClassificationSmall molecules
Mechanisms of ActionMatrix metalloproteinase-2 inhibitorsMatrix metalloproteinase 9 inhibitors
TargetsMatrix metalloproteinase 9Matrix metalloproteinase-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKotobuki Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKotobuki Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A